Header Molecular Tumor Diagnostics

Core Unit for Molecular Tumor Diagnostics

The Core Unit for Molecular Tumor Diagnostics (CMTD) is a research facility for the molecular characterization of sporadic and hereditary tumors based on next generation sequencing (NSG) techniques, bioinformatic analysis pipelines and interpretation of the results by experienced molecular pathologists and human geneticists. It is an essential and fundamental interface in the area of translational cancer research and clinical studies. The aim of the CMTD is the fast translation of novel molecular markers into clinical application by making indication-specific multi gene panels available. 

Service features:

CMTD Service features

Project request:

For a new project please fill in the CMTD request form and send them to: cmtd-service(at)nct-dresden.de

Please keep the project title short and unique for your project. As project description 2-3 short sentences about your project are sufficient. All other fields are optional, but will help us and you for a better planning of your project.

Applications:

Please contact us for consultation prior to sequencing projects. This will allow us to provide initial support in study design and therefore optimize the performance of the NGS experiments.
We offer high-throughput sequencing services, consultation and expert assistance in planning, sample preparation and method development.

Here are a few examples of what we offer:
 

NCT Dresden Tumor-Diagnostikgruppe

A wide range of next-generation sequencing (NGS) applications are used in a targeted manner to provide comprehensive answers to medical questions. © TUD/Stephan Wiegand

State-of-the-art high-throughput sequencing is used to study the genetic material of patients and changes in tumors. © TUD/Stephan Wiegand

Contact

Dr. rer. medic Sandra Oster
Coordinator Core Unit for Molecular Tumor Diagnostics
Tel.: +49 (0)351 458 11937
sandra.oster(at)nct-dresden.de
cmtd-service(at)nct-dresden.de

Directors

Prof. Dr. med. Gustavo Baretton
Director of the institute for pathology
Tel.: +49 (0) 351 458 3000
gustavo.baretton(at)uniklinikum-dresden.de

Prof. Dr. med. Evelin Schröck
Director of the institute for clinical genetics
Tel.: +49 (0) 351 458 5136
evelin.schrock(at)tu-dresden.de

Coordinators

Prof. Dr. med. Daniela Aust
Medical Coordinator
Institute for pathology
Tel.: +49 (0)351 458 3004
daniela.aust(at)uniklinikum-dresden.de

Dr. Sandra Oster
Scientific Coordinator
Core Unit for Molecular Tumor Diagnostic NCT/UCC
Tel.: +49 (0)351 458 11937
sandra.oster(at)nct-dresden.de

Staff

Dr. rer. nat. Stephan Drukewitz (Bioinformatician)
Tel. +49 (0)351   458 11327
stephan.drukewitz(at)nct-dresden.de

Dr. rer. nat. Doreen William (Biologist)
Tel.: +49 (0)351 458 11745
Doreen.William(at)nct-dresden.de

Alexander Krüger (MTA)
Tel.: +49 (0)351 458 16857
alexander.krüger(at)nct-dresden.de

M.Sc. Lisa Eckhardt (MTA)
Tel.: +49 (0)351 458 19621
lisa.eckhardt(at)nct-dresden.de

Sakshi Singh (PhD Bioinformatics)
Tel.: +49 (0)351 458 19904
sakshi.singh(at)nct-dresden.de